How to buy FSD Pharma stock | $1.77

FSD Pharma Inc is a drug manufacturers-specialty & generic business based in the US. FSD Pharma shares (HUGE) are listed on the NASDAQ and all prices are listed in US Dollars. FSD Pharma employs 9 staff and has a market cap (total outstanding shares value) of 0.00.

FSD Pharma stock price (NASDAQ: HUGE)

Use our graph to track the performance of HUGE stocks over time.

FSD Pharma shares at a glance

• Key figures

Information last updated 2021-07-30.

Latest market close	$1.77
52-week range	$1.28 - $4.44
50-day moving average	$1.72
200-day moving average	$1.92
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.02

Buy FSD Pharma shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy FSD Pharma stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of FSD Pharma Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

FSD Pharma price performance over time

Historical closes compared with the close of $1.77 from 2021-05-28

1 week (2021-07-22)	N/A
1 month (2021-07-02)	2.91%
3 months (2021-04-30)	-1.67%
6 months (2021-01-29)	N/A

1 year (2020-07-29)	N/A
2 years (2019-07-29)	N/A
3 years (2018-07-29)	N/A
5 years (2016-07-29)	N/A

Is FSD Pharma under- or over-valued?

Valuing FSD Pharma stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of FSD Pharma's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

FSD Pharma's EBITDA

FSD Pharma's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $428,232.

The EBITDA is a measure of a FSD Pharma's overall financial performance and is widely used to measure a its profitability.

FSD Pharma financials

Gross profit TTM	$-3,331,945
Return on assets TTM	-37.05%
Return on equity TTM	-60.26%
Profit margin	0%
Book value	$1.90
Market capitalisation	$61.5 million

TTM: trailing 12 months

Shorting FSD Pharma shares

There are currently 695,439 FSD Pharma shares held short by investors – that's known as FSD Pharma's "short interest". This figure is 0.8% down from 701,276 last month.

There are a few different ways that this level of interest in shorting FSD Pharma shares can be evaluated.

FSD Pharma's "short interest ratio" (SIR)

FSD Pharma's "short interest ratio" (SIR) is the quantity of FSD Pharma shares currently shorted divided by the average quantity of FSD Pharma shares traded daily (recently around 244872.88732394). FSD Pharma's SIR currently stands at 2.84. In other words for every 100,000 FSD Pharma shares traded daily on the market, roughly 2840 shares are currently held short.

However FSD Pharma's short interest can also be evaluated against the total number of FSD Pharma shares, or, against the total number of tradable FSD Pharma shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case FSD Pharma's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 FSD Pharma shares in existence, roughly 20 shares are currently held short) or 0.0205% of the tradable shares (for every 100,000 tradable FSD Pharma shares, roughly 21 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against FSD Pharma.

Find out more about how you can short FSD Pharma stock.

FSD Pharma share dividends

We're not expecting FSD Pharma to pay a dividend over the next 12 months.

Have FSD Pharma's shares ever split?

FSD Pharma's shares were split on a 1:201 basis on 15 October 2019. So if you had owned 201 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your FSD Pharma shares – just the quantity. However, indirectly, the new 20000% higher share price could have impacted the market appetite for FSD Pharma shares which in turn could have impacted FSD Pharma's share price.

FSD Pharma share price volatility

Over the last 12 months, FSD Pharma's shares have ranged in value from as little as $1.28 up to $4.44. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while FSD Pharma's is 1.0903. This would suggest that FSD Pharma's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

FSD Pharma overview

FSD Pharma Inc. , through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA. ; and with Innovet Italia S. R.

Frequently asked questions

What percentage of FSD Pharma is owned by insiders or institutions?
Currently 13.539% of FSD Pharma shares are held by insiders and 2.933% by institutions. How many people work for FSD Pharma?
Latest data suggests 9 work at FSD Pharma. When does the fiscal year end for FSD Pharma?
FSD Pharma's fiscal year ends in December. Where is FSD Pharma based?
FSD Pharma's address is: First Canadian Place, Toronto, ON, Canada, M5X 1A4 What is FSD Pharma's CUSIP number?
FSD Pharma's Committee on Uniform Securities Identification Procedures number is: 35954B206